Controller Medications in the Management of Bronchial Asthma

NCT01055041 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Moderate to Severe Persistent Bronchial Asthma

Interventions

DRUG: inhaled budesonide and formeterol plus oral montelukast
DRUG: inhaled budesonide and formeterol plus oral doxophylline
DRUG: Doubling the dose of inhaled budesonide and formeterol

Sponsor

Government Medical College, Bhavnagar